Viroj Wiwanitkit to Mass Screening
This is a "connection" page, showing publications Viroj Wiwanitkit has written about Mass Screening.
Connection Strength
0.760
-
Cryptococcal antigenemia screening among human immunodeficiency virus-infected cases with tuberculosis: Chance and cost effectiveness. Int J Mycobacteriol. 2018 Oct-Dec; 7(4):395-396.
Score: 0.180
-
Addressing the Global Zika Epidemic and Interprofessional Model of Universal Screening. J Perinat Neonatal Nurs. 2017 Oct/Dec; 31(4):284.
Score: 0.168
-
Microalbumin screening. Clin Chim Acta. 2010 Jul 04; 411(13-14):994; author reply 995.
Score: 0.099
-
Pooled Sample RT-PCR Test for COVID-19 Screening: Cost Reduction Analysis. Clin Lab. 2021 08 01; 67(8).
Score: 0.055
-
RT-PCR Tests for COVID-19: Observation on Use and Cost. Clin Lab. 2020 08 01; 66(8).
Score: 0.051
-
Imported Novel Coronavirus Infections: Observation on Active and Passive Case Detection in Thailand. Popul Health Manag. 2021 02; 24(1):149.
Score: 0.050
-
Screening for prostate cancer starting at age 50-54 years. J Cancer Res Ther. 2019 Mar; 15(Supplement):S177.
Score: 0.046
-
Re: If We Don't Ask, They Won't Tell: Screening for Urinary and Fecal Incontinence by Primary Care Providers. J Am Board Fam Med. 2019 Jan-Feb; 32(1):119.
Score: 0.046
-
Blood Bank and Diabetes Screening. Clin Lab. 2017 Jul 01; 63(7):1307-0.
Score: 0.041
-
Maternal and congenital syphilis in Haiti: a big problem. Rev Panam Salud Publica. 2010 Jun; 27(6):471.
Score: 0.025